Enkosi ngokundwendwela i-Nature.com. Inguqulelo yesikhangeli oyisebenzisayo inenkxaso enyiniweyo yeCSS. Ngowona mava angcono, sicebisa ukuba usebenzise isikhangeli esihlaziyiweyo (okanye uvale iModi yokuThelela kwi-Internet Explorer). Okwangoku, ukuqinisekisa inkxaso eqhubekayo, siya kunika isayithi ngaphandle kwezitayela kunye neJavaScript.
Iipeptides kunye neeproteni zisetyenziswa kakhulu ukunyanga izifo ezahlukeneyo, kodwa ngokuqhelekileyo kufuneka zitofwe kwaye umphumo wazo uhlala ixesha elifutshane. Ezi ntsilelo zezakhiwo zomthonyama zinokupheliswa ngoncedo lobunjineli beemolekyuli, kodwa lo ngumsebenzi onzima. Ubuchwephesha bobunjineli bemolekyuli, obuqale ukusetyenziswa kwi-insulin kwaye ngoku isetyenziswe ngempumelelo kwii-biopharmaceuticals ezininzi, zifuna ukukhutshwa kweepeptides kunye neeproteni ezivela kwi-acids enamafutha. Iimpawu ezithile kunye nendawo ye-fatty acids eqhotyoshelweyo inokubonelela ngeendlela ezahlukeneyo zokwandisa. Ukongezelela, le teknoloji inokubonelela ngesiqingatha sobomi obude emva kokulawulwa komlomo kwamachiza e-peptide, inokutshintsha ukuhanjiswa kweepeptide, kwaye inokuba namandla okujoliswa kwezicubu. Ngokhuseleko lwendalo lwe-fatty acids kunye neepropathi zekhemikhali ezichazwe kakuhle, obu buchwepheshe bubonelela ngendlela eguquguqukayo yokufunyanwa kweziyobisi ze-peptide kunye neprotheni.
Onke amaxabiso anethiwe. I-VAT iya kongezwa kamva ekuphumeni. Ubalo lwerhafu luya kwenziwa ekuphumeni.
Muttenthaler, M., King, GF, Adams, DJ & Alewood, PF Iindlela zokufunyanwa kweziyobisi ze-peptide. Muttenthaler, M., King, GF, Adams, DJ & Alewood, PF Iindlela zokufunyanwa kweziyobisi ze-peptide.Muttenthaler, M., King, GF, Adams, DJ kunye ne-Alevud, PF Iindlela zokufunyanwa kweziyobisi ze-peptide. Muttenthaler, M., Kumkani, GF, Adams, DJ & Alewood, PF 多肽药物发现的趋势. Muttenthaler, M., Kumkani, GF, Adams, DJ & Alewood, PFMuttenthaler, M., King, GF, Adams, DJ kunye ne-Alevud, PF Iindlela zokufunyanwa kweziyobisi ze-peptide.Sizwe Ukuvulwa komfundisi weziyobisi. 20, 309–325 (2021). Olu phononongo lugxile kwimiba yangoku neyexesha elizayo yokufunyanwa kwechiza le-peptide.
UMüller, TD, Blüher, M., Tschöp, MH & DiMarchi, RD Ukufunyanwa kweziyobisi ezichasene nokutyeba: ukuqhubela phambili kunye nemingeni. UMüller, TD, Blüher, M., Tschöp, MH & DiMarchi, RD Ukufunyanwa kweziyobisi ezichasene nokutyeba: ukuqhubela phambili kunye nemingeni.UMüller, TD, Blucher, M., Chop, MH kunye neDiMarchi, i-RD Anti-obesity ukufunyanwa kweziyobisi: inkqubela kunye nemingeni. Müller, TD, Blüher, M., Tschöp, MH & DiMarchi, RD 抗肥胖药物发现：进展和挑战。 Müller, TD, Blüher, M., Tschöp, MH & DiMarchi, RDUMüller, TD, Blucher, M., Chop, MH kunye neDiMarchi, i-RD Anti-obesity ukufunyanwa kweziyobisi: inkqubela kunye nemingeni.Sizwe Ukuvulwa komfundisi weziyobisi. 21, 201-223 (2022). Olu phononongo lubonelela ngembono kwiingxaki zokutyeba, ngakumbi iikhonsepthi ezintsha ezisekwe kwiipeptides.
I-Strohl, iiprotheyini ze-WR Fusion ukwandisa isiqingatha sobomi bebhayoloji njengesona sicwangciso sebhayoloji. I-Biopharmaceutics 29, 215-239 ​​(2015).
Evans, M. et al. Ukuthotyelwa kunye nokuphikelela kweziyobisi ze-antidiabetic kunye nokudibanisa neziphumo zeklinikhi kunye nezoqoqosho kwizigulane ezinesifo sikashukela sohlobo lwe-2: ukuphononongwa ngokuchanekileyo kweencwadi. ukutyeba kweswekile. imetabolism. 24, 377-390 (2022).
I-Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JH Iimbono zesigulane kwiyeza kunye neveki ye-diabetes. I-Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JH Iimbono zesigulane kwiyeza kunye neveki ye-diabetes.I-Polonsky WH, i-Fisher L., i-Hessler D., i-Brune D., kunye ne-Best JH Imbono yesigulana kumayeza esifo seswekile kanye ngeveki. Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JH 患者对每周一次的糖尿病药物的看法. Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JHI-Polonsky WH, i-Fisher L., i-Hessler D., i-Brune D., kunye ne-Best JH i-Parent perception yamayeza e-diabetes kanye ngeveki.ukutyeba kweswekile. imetabolism. 13, 144-149 (2011).
Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Synthesis of palmitoyl derivatives of insulin and their biological activities. Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Synthesis of palmitoyl derivatives of insulin and their biological activities.Hashimoto M., Takada K., Kiso Y. kunye ne-Muranishi S. Synthesis ye-palmitoyl derivatives ye-insulin kunye nomsebenzi wabo we-biological. Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. 胰岛素棕榈酰衍生物的合成及其生物活性. Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Synthesis kunye nomsebenzi we-biological we-insulin palmitoyl derivatives.Hashimoto M., Takada K., Kiso Y. kunye ne-Muranishi S. Synthesis kunye nomsebenzi we-biological we-insulin palmitoyl derivatives.indawo yokugcina amayeza 6, 171-176 (1989).
Kurtzhals, P. et al. I-Albumin ibophelela kwi-insulin enamafutha e-acid-acylated: ukubonakaliswa kwe-ligand-protein interactions kunye nokulungelelaniswa phakathi kokubopha ubudlelwane kunye nexesha lesenzo se-insulin kwi-vivo. biochem. J. 312, 725–731 (1995). Lo msebenzi ungowokuqala ukubonisa ukwanda kwesiqingatha sobomi ngenxa yokubophelela kwe-albumin kwiipeptides ezivela kwi-fatty acids.
Mejuch, T. & Waldmann, H. Ukuhlanganiswa kweeprotheni ezine-lipidated. Mejuch, T. & Waldmann, H. Ukuhlanganiswa kweeprotheni ezine-lipidated.Meyukh, T. kunye noWaldmann, H. Ukuhlanganiswa kweeprotheni ezine-lipidated. Mejuch, T. & Waldmann, H. 脂化蛋白质的合成. Mejuch, T. kunye noWaldmann, H.Meyukh, T. kunye noWaldmann, H. Ukuhlanganiswa kweeprotheni ezine-lipidated.Bioconjugate. Ikhemikhali. 27, 1771-1783 (2016).
I-Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. Iprotheyini ye-lipidation kwi-cell signaling kunye nezifo: umsebenzi, ukulawulwa, kunye namathuba okunyanga. I-Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. Iprotheyini ye-lipidation kwi-cell signaling kunye nezifo: umsebenzi, ukulawulwa, kunye namathuba okunyanga.I-Chen B., i-Sun Y., i-Niu J., i-Jarugumilli GK kunye ne-Wu X. I-protein lipidation kwi-cell signaling kunye nesifo: umsebenzi, ukulawulwa, kunye namandla onyango. Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. 细胞信号和疾病中的蛋白质脂化：功能、调节和治疗机会。 Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. Protein脂化 kwisignali yeseli kunye nesifo: umsebenzi, ukulawulwa kunye namathuba onyango.I-Chen B., i-Sun Y., i-Niu J., i-Jarugumilli GK kunye ne-Wu X. I-protein lipidation kwi-cell signaling kunye nesifo: umsebenzi, ukulawulwa, kunye namandla onyango.icytochemistry. ibhayoloji 25, 817-831 (2018).
Richter, WF, Bhansali, SG & Morris, ME Mechanistic determinants of biotherapeutics absorption following SC administration. Richter, WF, Bhansali, SG & Morris, ME Mechanistic determinants of biotherapeutics absorption following SC administration.I-Richter, i-VF, i-Bhansali, i-SG kunye ne-Morris, i-ME Iinkqubo ezimisela ukufunxwa kwee-agent ze-biotherapeutic emva kokulawulwa kwe-subcutaneous. Richter, WF, Bhansali, SG & Morris, ME SC 给药后生物治疗药物吸收的机制决定因素. Richter, WF, Bhansali, SG & Morris, ME SC Richter, WF, Bhansali, SG & Morris, ME SC Механистические детерминанты абсорбции биотерапевтических препаратов после введения. I-Richter, i-WF, i-Bhansali, i-SG & no-Morris, i-ME SC I-Mechanistic determinants of absorption of biotherapeutic drugs after administration.I-AAPS J. 14, 559–570 (2012).
uGradel, AKJ et al. Izinto ezichaphazela ukufunxwa kwe-insulin engaphantsi kwesikhumba: iimpembelelo zokuguquguquka. J. Diabetes Res. 2018, 1205121 (2018).
U-Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Ukusabalalisa kunye ne-polymerization inquma ukuxutywa kwe-insulin kwi-subcutaneous tissue kwizigulane zesifo sikashukela. U-Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Ukusabalalisa kunye ne-polymerization inquma ukuxutywa kwe-insulin kwi-subcutaneous tissue kwizigulane zesifo sikashukela. I-Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. U-Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Ukusabalalisa kunye ne-polymerization kunquma ukuxutywa kwe-insulin kwi-subcutaneous tissue kwizigulane zesifo sikashukela. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. 扩散和聚合决定了糖尿病患者皮下组织对胰岛组。 Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. I-Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. U-Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Ukusasazwa kunye nokudibanisa kugqiba ukuxutywa kwe-insulin engaphantsi kwe-insulin kwizigulane zesifo sikashukela.ukuskena. J. Klin. ilabhoratri. tyala imali. 45, 685-690 (1985).
UMosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B. Imodeli yokufunxa kinetics ye-insulin enyibilikayo ene-subcutaneous. UMosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B. Imodeli yokufunxa kinetics ye-insulin enyibilikayo ene-subcutaneous.UMosekilde E, uJensen KS, iBinder S, iPramming S, kunye noThorsteinsson B. Ukulinganisa i-kinetics yokufunxa ye-insulin enyibilikayo engaphantsi kwe-subcutaneous. Mosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B. 模拟皮下注射可溶性胰岛素的吸收动力学。 UMosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B.UMosekilde E, uJensen KS, iBinder S, iPramming S, kunye noThorsteinsson B. Ukulinganisa i-kinetics yokufunxa ye-insulin enyibilikayo elawulwa ngaphantsi kwesikhumba.J. Pharmacokinetics. biopharmacy. 17, 67–87 (1989).
Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Ubungakanani bemolekyuli bumodareyitha i-pharmacokinetics, i-biodistribution, kunye ne-renal deposition yokuhanjiswa kweziyobisi i-biopolymer elastin-like polypeptide. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Ubungakanani bemolekyuli bumodareyitha i-pharmacokinetics, i-biodistribution, kunye ne-renal deposition yokuhanjiswa kweziyobisi i-biopolymer elastin-like polypeptide. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Размер молекулы модулирует фармакокинетику для доставки лекарственного средства. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Ubungakanani bemolekyuli bulungelelanisa i-pharmacokinetics, i-biodistribution, kunye ne-renal deposition ye-biopolymeric elastin-like polypeptide yokuhanjiswa kweziyobisi. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III分子大小调节药物递送生物聚合物弹性蛋白樣多肽的药代动力学、生物分布和肾。 Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Molecule 大小名行电影送送biological polymer elastic protein isampuluKuna, M., Mahdi, F., Chad, AR kunye neBidwell, GL III. I-Pharmacokinetics, i-biodistribution kunye ne-renal deposition ye-biopolymeric elastin-like polypeptides modulating ubukhulu be-molecule.isayensi Ingxelo 8, 7923 (2018).
Harris, JM, Martin, NE & Modi, M. Pegylation: inkqubo yenoveli yokuguqula i-pharmacokinetics. Harris, JM, Martin, NE & Modi, M. Pegylation: inkqubo yenoveli yokuguqula i-pharmacokinetics. IHarris, JM, Martin, NE & Modi, M. Пегилирование: новый процесс модификации фармакокинетики. Harris, JM, Martin, NE & Modi, M. Pegylation: inkqubo yenoveli yokuguqula i-pharmacokinetics. Harris, JM, Martin, NE & Modi, M. 聚乙二醇化：一种改变药代动力学的新方法. Harris, JM, Martin, NE & Modi, M. 聚乙二感化: indlela entsha yokutshintsha iyeza. IHarris, JM, Martin, NE & Modi, M. Пегилирование: новый подход к изменению фармакокинетики. Harris, JM, Martin, NE & Modi, M. Pegylation: indlela entsha yokutshintsha i-pharmacokinetics.klinikhi. Pharmacokinetics. 40, 539-551 (2001).
Elmerer, M. et al. Ukulinganiswa kwe-albumin ye-interstitial kwi-skeletal muscle yomntu kunye nezicubu ze-adipose ngokuvula ukuhamba kwe-microperfusion. Ewe. J. Physiology. endocrine. imetabolism. 278, E352-E356 (2000).
Nelson, J. et al. Ubomi besiqingatha eside se-albumin ebantwini bufuna i-C-terminus engaguqukiyo. nxibelelana. ibhayoloji. 3, 181 (2020).
Chowdhury, K. et al. I-Fc receptor (FcRn) ye-IgG ehambelana neyona nto ibalulekileyo ye-histocompatibility complex ibopha i-albumin kwaye yandise ubomi bayo. J. Exp. iyeza. 197, 315-322 (2003).
Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Exocytosis ye-IgG njengoko idibene ne-receptor, i-FcRn: uhlalutyo kwinqanaba le-molecule enye. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Exocytosis ye-IgG njengoko idibene ne-receptor, i-FcRn: uhlalutyo kwinqanaba le-molecule enye. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Экзоцитоз IgG, опосредованный рецептором FcRn: анализ на уровне одной молекулы. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES FcRn receptor-mediated IgG exocytosis: uhlalutyo lwe-molecule enye. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES 受体介导的IgG 胞吐作用，FcRn:单分子水平的分析。 Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, Экзоцитоз IgG, опосредованный рецептором ES, FcRn: анализ на уровне одной молекулы. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES receptor-mediated IgG exocytosis, FcRn: uhlalutyo lwenqanaba le-molecule enye.inkqubo. IZiko leSizwe leNzululwazi. inzululwazi. US 101, 11076 (2004).
Yena, i-XM & Carter, i-DC Atomic isakhiwo kunye nekhemikhali ye-albumin ye-serum yabantu. Yena, i-XM & Carter, i-DC Atomic isakhiwo kunye nekhemikhali ye-albumin ye-serum yabantu.Kwi, i-XM kunye neCarter, i-DC Atomic isakhiwo kunye nekhemikhali ye-albumin ye-serum yabantu. Yena, XM & Carter, DC 人血清白蛋白的原子结构和化学。 Yena, XM & Carter, DC.Kwi, i-XM kunye neCarter, i-DC Atomic isakhiwo kunye nekhemikhali ye-albumin ye-serum yabantu.Indalo 358, 209-215 (1992).
Curry, S., Mandelkow, H., Brick, P. & Franks, N. Isakhiwo seCrystal se-albumin ye-serum yabantu ehlanganiswe ne-fatty acid ibonisa ukuhanjiswa kwe-asymmetric yeendawo ezibophelelayo. Curry, S., Mandelkow, H., Brick, P. & Franks, N. Isakhiwo seCrystal se-albumin ye-serum yabantu ehlanganiswe ne-fatty acid ibonisa ukuhanjiswa kwe-asymmetric yeendawo ezibophelelayo.Curry S., Mandelkow H., Brick P. kunye noFranks N. Isakhiwo sekristal se-albumin ye-serum yabantu kwi-complex ene-fatty acid ibonisa ukusabalalisa kwe-asymmetric yeendawo ezibophezelayo. Curry, S., Mandelkow, H., Brick, P. & Franks, N. Curry, S., Mandelkow, H., Brick, P. & Franks, N. Isakhiwo sekristale seprotein emhlophe ye-serum yabantu kunye ne-fatty acids ibonisa ukusabalalisa kwe-asymmetric yeendawo ezibophelelayo.Curry S., Mandelkow H., Brick P. kunye noFranks N. Isakhiwo sekristal se-albumin ye-serum yabantu eyinkimbinkimbi kunye ne-fatty acids ibonisa ukusabalalisa kwe-asymmetric yeendawo ezibophelelayo.Nat. isakhiwo. ibhayoloji 5, 827-835 (1998). Eli phepha libonisa isiseko sesakhiwo sokubopha i-fatty acids kwi-serum albumin.
Irby, D., Du, C. & Li, F. Lipid-drug conjugate ukwenzela ukuhanjiswa kweziyobisi. Irby, D., Du, C. & Li, F. Lipid-drug conjugate ukwenzela ukuhanjiswa kweziyobisi.Irby, D., Du, K. kunye ne-Li, F. I-Lipid-drug conjugates ukwenzela ukuhanjiswa kwechiza okuphuculweyo. Irby, D., Du, C. & Li, F. Lipid-drug conjugate yokuphucula ukuhanjiswa kwechiza. Irby, D., Du, C. & Li, F. Lipid-drug conjugate yokuphucula ukuhanjiswa kwechiza.Irby, D., Du, K. kunye ne-Li, F. I-Lipid-drug conjugate ukwenzela ukuhanjiswa kwechiza okuphuculweyo.I-Biochemistry 14, 1325-1338 (2017).
Torchilin VP Inkqubela phambili yakutsha nje kwicandelo le-liposomes njengabathwali beziyobisi. Sizwe Ukuvulwa komfundisi weziyobisi. 4, 145-160 (2005).
Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Amathuba kunye nemingeni ye-fatty acid conjugated therapeutics. Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Amathuba kunye nemingeni ye-fatty acid conjugated therapeutics.Bhat, M., Jatyan, R., Mittal, A., Mahato, RI kunye neChitkara, D. Amathuba kunye nemingeni ye-fatty acid conjugated therapeutics. Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. 脂肪酸共轭疗法的机遇和挑战. Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Fatty acid 共续电影的机遇和challenge.Bhat M., Jatyan R., Mittal A., Mahato RI kunye neChitkara D. Amathuba kunye nemingeni ye-fatty acid conjugation therapy.Ikhemikhali. i-physics Lipids 236, 105053 (2021).
Smith, R. & Tanford, C. I-Hydrophobicity ye-chain chain n-alkyl carboxylic acids, njengoko ilinganiswe ngokusasazwa kwabo phakathi kwe-heptane kunye nezisombululo zamanzi. Smith, R. & Tanford, C. I-Hydrophobicity ye-chain chain n-alkyl carboxylic acids, njengoko ilinganiswe ngokusasazwa kwabo phakathi kwe-heptane kunye nezisombululo zamanzi.Smith, R. kunye neTanford, K. I-Hydrophobicity ye-long-chain n-alkylcarboxylic acids elinganiswa ngokusasazwa kwabo phakathi kwe-heptane kunye nezisombululo zamanzi. USmith, R. & Tanford, C. Smith, R. & Tanford, C. I-hydrophobicity ye-长链正alkylcarboxylate, ilinganiswa ngokusasazwa kwabo phakathi kwe-hydrogen peroxide kunye nesisombululo samanzi.Smith, R. kunye neTanford, K. I-Hydrophobicity ye-long-chain n-alkylcarboxylic acids elinganiswa ngokusasazwa kwabo phakathi kwe-heptane kunye nezisombululo zamanzi.inkqubo. IZiko leSizwe leSayensi. isayensi US 70, 289 (1973).
ULiu, J. et al. Kanye ngeveki ukufunyanwa kwe-semaglutide analog ye-glucagon-like peptide-1 (GLP-1). J. Amayeza. Ikhemikhali. 58, 7370-7380 (2015). Lo msebenzi ubonisa okokuqala ithuba lokusebenzisa kanye ngeveki iindlela ze-fatty derivatization.
Østergaard, S. et al. Impembelelo ye-PYY3-36 yabantu i-dibasic fatty acylation kwi-mini-pig Y2 receptor umsebenzi kunye nesiqingatha sobomi. inzululwazi. Ingxelo 11, 21179 (2021). Eli nqaku libonisa ukubaluleka kwe-fatty acid position, ikhonkco kunye nokuzinza kwe-backbone ekuphuhliseni i-analog ye-PYY emide yesiqingatha sobomi.
Ensenat-Vaser, R. et al. Ukungena kwe-myristoylated peptides kwi-membrane yeseli kwajongwa ngokuthe ngqo kusetyenziswa i-confocal fluorescence microscopy. IUBMB Ubomi 54, 33-36 (2002).
Nelson, AR, Borland, L., Allbritton, NL & Sims, CE Myristoyl-based based transport of peptides kwiiseli eziphilayo. Nelson, AR, Borland, L., Allbritton, NL & Sims, CE Myristoyl-based based transport of peptides kwiiseli eziphilayo.Nelson AR, Borland L, Allbritton NL. kunye Sims SE Peptide ukuthuthwa kwiiseli eziphilayo zisekelwe myristoyl. Nelson, AR, Borland, L., Allbritton, NL & Sims, CE 基于肉豆蔻酰的肽转运到活细胞中。 UNelson, AR, Borland, L., Allbritton, NL & Sims, CE.Nelson, AR, Borland, L., Albritton, NL. kunye ne-Sims, KE Uthutho lwee-peptides ezisekelwe kwi-myristoyl kwiiseli eziphilayo.I-Biochemistry 46, 14771-14781 (2007).
I-Kabanov, i-AV, i-Levashov, i-AV & ne-Alakhov, i-VY Lipid ukuguqulwa kweeprotheni kunye ne-membrane yazo yokuthutha. I-Kabanov, i-AV, i-Levashov, i-AV & ne-Alakhov, i-VY Lipid ukuguqulwa kweeprotheni kunye ne-membrane yazo yokuthutha.Kabanov AV, Levashov AV, Alakhov V.Yu. Ukuguqulwa kweeprotheni kunye ne-membrane yazo yokuthutha. Kabanov, AV, Levashov, AV & Alakhov, VY 蛋白质的脂质修饰及其膜转运. Kabanov, AV, Levashov, AV & Alakhov, VYI-Kabanov AV, i-Levashov AV, i-Alakhov, i-Lipid ukuguqulwa kweeprotheni ze-VY kunye nokuthutha i-membrane yazo.ubunjineli beeprotheyini. Disemba Searl. 3, 39–42 (1989).
I-Gao, i-X., i-Mazière, i-AD, i-Beard, i-R., i-Klumperman, i-J. & i-Hannoush, i-RN i-Fatty acylation iphucula i-cellular internalization kunye nokusabalalisa i-cytosolic ye-cystine-knot peptide. I-Gao, i-X., i-Mazière, i-AD, i-Beard, i-R., i-Klumperman, i-J. & i-Hannoush, i-RN i-Fatty acylation iphucula i-cellular internalization kunye nokusabalalisa i-cytosolic ye-cystine-knot peptide.I-Gao, i-X., i-Mazier, i-AD, i-Byrd, i-R., i-Klumperman, i-J. kunye ne-Hannoosh, i-RN i-Fatty acid acylation iphucula i-cellular internalization kunye nokusabalalisa i-cytosolic ye-peptide ene-cystine loop. Gao, X., Mazière, AD, Beard, R., Klumperman, J. & Hannoush, RN 脂肪酰化增强了胱氨酸结肽的细胞内化和胞质分布。 Gao, X., Mazière, AD, Beard, R., Klumperman, J. & Hannoush, RN.I-Gao, i-X., i-Mazier, i-AD, i-Byrd, i-R., i-Klumperman, i-J. kunye ne-Hannoosh, i-RN Fatty acylation iphucula ukufakwa ngaphakathi kweselula kunye nokusabalalisa i-cytoplasmic ye-cystine peptides.iScience 24, 103220 (2021).
Baker, EM et al. Ukuguqulwa kobomi besiqingatha-obude be-YY3-36 peptide ye-receptor-mediated internalization ngqo. Moore. iyeza. 16, 3665–3677 (2019).
Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meiler, J. & Beck-Sickinger, AG Isikhundla kunye nobude be-fatty acids buchaphazela kakhulu i-receptor selectivity pattern of human pancreatic polypeptide analogues. Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meiler, J. & Beck-Sickinger, AG Isikhundla kunye nobude be-fatty acids buchaphazela kakhulu i-receptor selectivity pattern of human pancreatic polypeptide analogues.Yenziwe, W., Bellmann-Sickert, K., Kaiser, A., Mailer, J. kunye no-Beck-Sickinger, AG Isikhundla kunye nobude be-fatty acids buchaphazela kakhulu indlela yokukhetha i-pancreas polypeptide analog receptors. Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meil ​​er, J. & Beck-Sickinger, AG脂肪酸的位置和长度强烈影响人胰腺多肽类似物的受体选择性模式. Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meil ​​er, J. & Beck-Sickinger, AGYenziwe, W., Bellmann-Sickert, K., Kaiser, A., Mailer, J. kunye no-Beck-Sickinger, AG Isikhundla kunye nobude be-fatty acids buchaphazela kakhulu indlela yokukhetha i-pancreas analog polypeptide receptors.HimMedChem 9, 2463–2474 (2014).
Aleksopoulou, F. et al. I-lipid metabolite PrRP31 yi-GPR10 esebenza ixesha elide kunye ne-NPFF2 ye-receptor agonist enemiphumo enamandla yokulahlekelwa kwesisindo. inzululwazi. Ingxelo 12, 1696 (2022). Olu phononongo lwe-methodological lugxininisa umahluko phakathi kwe-mono- kunye ne-diacid side chain.
Poulsen, K. et al. Uphuhliso olunengqiqo lwee-agonists ezizinzileyo ze-Y2 receptor peptide PYY3-36. iyeza. itanki yokugcina. 38, 1369-1385 (2021).
Conde-Frieboes, K. et al. Ukuchongwa kunye nokubonakaliswa kwe-in vitro kunye ne-vivo analogues ze-melanocortin ezithatha ixesha elide kunye nezikhethiweyo ze-4 receptor (MC4-R) i-alpha-melanocyte-stimulating hormone (alpha-MSH). J. Amayeza. Ikhemikhali. 55, 1969-1977 (2012).
URamirez-Andersen, HS et al. I-analogues ye-hormone yokukhula komntu ehlala ixesha elide ibotshelelwe kwi-albumin engabonakaliyo. Bioconjugate. Ikhemikhali. 29, 3129-3143 (2018).
Madsen, K. et al. Ubudlelwane bomsebenzi wesakhiwo kunye nokwandiswa kwezinto ezithatha ixesha elide zeglucagon-like peptide-1: ukubaluleka kobude be-asidi enamafutha, i-polarity, kunye nomthamo. J. Amayeza. Ikhemikhali. 50, 6126-6132 (2007).
Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Izinto eziphuma kabini ze-GLP-1. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Izinto eziphuma kabini ze-GLP-1. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Дважды ацилированные производные GLP-1. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Izinto eziphuma kabini ze-acylated ze-GLP-1. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. 双酰化GLP-1 衍生物。 Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. 双酰化GLP-1 衍生物。 Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Диацилированные производные GLP-1. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. I-Diacylated derivatives ye-GLP-1.I-Patent yase-US WO2012/140117 (2012).
Omncinci, uP.-Yu. Yima. I-analogues enamandla, esebenza ixesha elide ye-GLP-1 eyenzelwe ukuhanjiswa kwe-transdermal ngokusekelwe kwi-microstructure. inkqubo. IZiko leSizwe leNzululwazi. inzululwazi. US 113, 4140-4145 (2016).
Royalty, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS UPhando lokhuseleko, ukunyamezela, i-pharmacokinetics, kunye ne-pharmacodynamics yedosi enye kunye neninzi ye-analog ye-α-MSH yexesha elide ekugqithiseni okunempilo kunye nokutyeba. izifundo. Royalty, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS UPhando lokhuseleko, ukunyamezela, i-pharmacokinetics, kunye ne-pharmacodynamics yedosi enye kunye neninzi ye-analog ye-α-MSH yexesha elide ekugqithiseni okunempilo kunye nokutyeba. izifundo.I-Royalty, i-JE, i-Konradsen, i-G., i-Eskerod, i-O., i-Wolf, i-BS kunye ne-Hansen, i-BS yoKhuseleko, ukunyamezela, i-pharmacokinetics, kunye ne-pharmacodynamics yokufundwa kweedosi ezilodwa kunye ezininzi ze-analog ye-α-MSG yexesha elide kwizifundo eziphilileyo kunye ne-obese.版税, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS 单剂量和多剂量长效α-MSH类似物在健康超重和肥胖患者中的安全性、耐受性、药代动力学和药效学研究科目。版税, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS Idosi enye kunye nedosi eninzi enesiphumo eside α-MSH全健康超重和肥胖可以中可以可以而受性、药代报学学和药效学研究科目。Ubukhosi, i-JE, i-Konradsen, i-G., i-Eskerod, i-O., i-Wolf, i-BS kunye ne-Hansen, i-BS yoKhuseleko, ukunyamezela, i-pharmacokinetics ye-dose enye kunye ne-multiple ye-alpha-MSG ye-analogues ye-alpha-MSG ephilileyo kwizifundo ezinempilo kunye ne-obese. I-Kinetics kunye ne-pharmacodynamics.J. Clin. Pharmacodynamics. 54, 394-404 (2014).
Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H. Novel glucagon analogue. Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H. Novel glucagon analogue.ULau, J., F., Kruse, T., Linderoth, L. kunye noTogersen, H. I-analogues entsha yeglucagon. Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H. 新型胰高血糖素类似物。 ULau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H.ULau, J., F., Cruz, T., Linderoth, L. kunye noTogersen, H. I-analogues entsha yeglucagon.I-Patent yase-US WO2011/117416 A1 (2011).
Ward, BP et al. Ukukhutshwa kweepeptides kuzinzisa izakhiwo zokuphucula ukusebenza kwebhayoloji. Moore. imetabolism. 2, 468-479 (2013). Lo msebenzi ubonisa indima ye-fatty acid side chain ekuqinisekiseni ukuzinza kwesakhiwo kunye nokubopha i-peptide receptors yamachiza.
Koskun T. et al. I-LY3298176, i-novel ye-GIP ye-GIP kunye ne-GLP-1 ye-receptor agonist yonyango lwe-2 yeswekile: ukusuka ekufumaneni ubungqina beklinikhi yombono. Moore. imetabolism. 18, 3-14 (2018). Eli phepha libonisa ukuyila kwe-fatty acid-derived GLP-1 / GIP co-agonist yokuqala ye-acid-derived for once-weekly administration in eklinikhi.
Kjeldsen, TB et al. Ubunjineli bemolekyuli ye-insulin ye-icodec, i-analog yokuqala ye-insulin ye-acylated kanye ngeveki ebantwini. J. Amayeza. Ikhemikhali. 64, 8942-8950 (2021). Eli phepha libonisa uphuhliso lokuqala lwe-acid enamafutha avela kwi-insulin yolawulo kanye ngeveki.
van Witteloostein, SB et al. I-Neoglycolipids ye-peptides esebenza ixesha elide: i-analogs yokuzihlanganisa ye-glucagon-like peptide 1 eneempawu zokubopha i-albumin kunye ne-vivo potency ephezulu. Moore. iyeza. 14, 193-205 (2017).
Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. I-acylated heptapeptide ibopha i-albumin kunye nobudlelwane obuphezulu kunye nesicelo njengoko ithegi inika iipeptide ezisebenza ixesha elide. Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. I-acylated heptapeptide ibopha i-albumin kunye nobudlelwane obuphezulu kunye nesicelo njengoko ithegi inika iipeptide ezisebenza ixesha elide.Zorzi, A., Middendorp, SJ, Wilbs, J., Dale, K. kunye noHaynes, S. I-acylated heptapeptide ibopha i-albumin kunye nobudlelwane obuphezulu, kunye nokusetyenziswa kwayo njengelebula kunika i-peptide yexesha elide. Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. 鎄化七peptide以高亲和力设计白白约筒，使用于设计手机。Zorzi, A., Middendorp, SJ, Wilbs, J., Dale, K. kunye noHaynes, S. I-Acylated heptapeptides ibopha i-albumin kunye nobudlelwane obuphezulu kwaye isebenze njengeelebhile zokuhanjiswa kwexesha elide le-peptide.Nat. ukunxibelelana 8, 16092 (2017).